
VYLR · NYSE
Consensus is -$0.03 EPS for Dec 2026 across 5 estimates, ranging -$0.08 to $0.01.
Vylor’s September quarter was a modest revenue decline paired with a slightly wider adjusted operating loss, with the GAAP loss also burdened by separation costs. Pro forma net sales of $938 million were down 0.6% from $944 million a year earlier, and organic sales were $911 million. Adjusted pro forma operating EPS was a loss of $0.42, 4.55% better than the $0.44 loss expected, but a little worse than the $0.41 loss in Q3 FY2025. GAAP pro forma loss from continuing operations attributable to Vylor widened to $480 million, or $0.72 per diluted share, from $391 million, or $0.58, in the year-ago quarter. Against the prior quarter’s reported $1.02 billion net income, Q3’s loss also reflects the sharp seasonal swing in the business.
The defining factors were weaker organic sales, pressure on adjusted operating results, and the costs of becoming a standalone company. Price and product mix fell 3%, partly offset by 6% volume growth, while currency was a 9% headwind to reported sales. Adjusted pro forma operating EBITDA was negative $269 million versus negative $202 million a year earlier. Separation costs rose to $99 million from $7 million. For the first nine months, however, pro forma sales grew 4% to $8.531 billion and adjusted EPS increased to $2.37 from $2.23, even as net income from continuing operations attributable to Vylor fell to $1.005 billion from $1.228 billion.
Vylor became an independent public company on October 1, 2026, immediately after the quarter. The pre-separation pro forma results include $99 million of separation costs, up from $7 million in Q3 FY2025, and $228 million for the first nine months versus $7 million a year earlier. These costs are a major reason the GAAP loss was materially larger than the adjusted loss; adjusted EPS also excludes amortization of legacy intangibles and other specified items. The release reported nine-month adjusted operating EPS of $2.37, up from $2.23, despite lower pro forma net income from continuing operations attributable to Vylor of $1.005 billion versus $1.228 billion.